Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

08.07.16	Pfizer: S-TRAC Trial Results Of SUTENT Meets Primary Endpoint - Quick Facts (RTTNews)
07.07.16	Nanobiotix Takes A Big Step, VRTX Broadens Pipeline, PFE Aims High With Javelin (RTTNews)
06.07.16	Merck, Pfizer Initiate Phase III Trial To Evaluate Avelumab - Quick Facts (RTTNews)
06.07.16	Merck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer (Businesswire)
06.07.16	Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer (Businesswire)
28.06.16	Pfizer Says SPIRE-HR And SPIRE-FH Trials Meet Primary Endpoints (RTTNews)
28.06.16	Pfizer To Invest About $350 Mln In Global Biotechnology Center In China (RTTNews)
24.06.16	Pfizer Completes Acquisition Of Anacor Pharma (RTTNews)
15.06.16	CHMA Trims Workforce, INFI's DYNAMO Disappoints, Marathon Joins DMD Race (RTTNews)
14.06.16	Shire To License IBD Drug PF-00547659 From Pfizer; Terms Not Disclosed (RTTNews)
10.06.16	ICON Signs 3-year Deal With Pfizer; Terms Not Disclosed - Quick Facts (RTTNews)
10.06.16	PAREXEL To Continue To Provide Research, Development Services To Pfizer (RTTNews)
09.06.16	FDA Panel Nod For PFE, INSM Withdraws MAA, FCSC's Voice Fades Out (RTTNews)
09.06.16	Pfizer : FDA Panel Recommends ALO-02 Extended-Release Capsules For Approval (RTTNews)
07.06.16	Pfizer Announces Positive Results From Second Phase 3 Trial Of Oral XELJANZ (RTTNews)
06.06.16	Pfizer Says Pivotal Avelumab Study Shows Positive Results In MCC (RTTNews)
06.06.16	ASCO 2016: Pivotal Avelumab Study Shows Positive Results in Metastatic Merkel Cell Carcinoma (Businesswire)
06.06.16	Pfizer Announces New Data From Phase 1/2 Study Of Lorlatinib (RTTNews)
04.06.16	Pfizer Reports Encouraging Safety Data For Novel Immunotherapy Combinations (RTTNews)
31.05.16	BioRap Tech Collaborates With Pfizer To Research &Develop Novel Immunomodulators (RTTNews)
29.05.16	Biotech Stocks Facing FDA Decision In June (RTTNews)
23.05.16	Pfizer Reports Label Update For CHAMPIX In European Union - Quick Facts (RTTNews)
23.05.16	CHAMPIX® (varenicline) European Union Label Updated to Include New Safety and Efficacy Data from the EAGLES Clinical Trial Following Endorsement from CHMP (Businesswire)
20.05.16	Pfizer: EMA Accepts Trumenba's Marketing Authorization Application For Review (RTTNews)
20.05.16	Pfizer Announces European Medicines Agency Acceptance for Review of Marketing Authorization Application for TRUMENBA® (Meningococcal Group B Vaccine) (Businesswire)
19.05.16	Spark, Pfizer Announce Data From Initial Subjects In Hemophilia B Trial (RTTNews)
19.05.16	Merck KGaA, Pfizer To Present Avelumab Data In Seven Different Cancers At ASCO (RTTNews)
18.05.16	Merck and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting (Businesswire)
16.05.16	Anacor Jumps On Takeover By Pfizer (RTTNews)
16.05.16	Pfizer To Acquire Crisaborole Developer Anacor Pharma In $5.2 Bln Deal (RTTNews)
16.05.16	Pfizer To Buy Crisaborole Developer Anacor Pharma For $5.2 Bln - Quick Facts (RTTNews)
05.05.16	WAVE Life Sciences Enters Into Research, License And Option Deal With Pfizer (RTTNews)
03.05.16	Pfizer Q1 Results Top Estimates, Raises 2016 Outlook; Stock Up (RTTNews)
03.05.16	Pfizer Inc. Q1 Profit Climbs 30% (RTTNews)
28.04.16	Pfizer Agrees To Pay $784.6 Mln To Settle Drug Discount Case (RTTNews)
27.04.16	BEAT Upbeat, COLL Gets Final FDA Nod, CPRX Crushed (RTTNews)
26.04.16	Pfizer Announces Patient Enrollment Completion In SPIRE-2 Cardiovascular Trial (RTTNews)
20.04.16	MOH Opens Wallet, PFE's Ibrance A Step Closer To Full Approval, SGYP To Face FDA (RTTNews)
19.04.16	Pfizer Reports Positive Top-Line Results For Phase 3 PALOMA-2 Trial Of IBRANCE (RTTNews)
16.04.16	NY Attorney General Sues CDPHP For Unlawfully Denying Coverage Of HCV Treatment (RTTNews)
07.04.16	Pfizer, IBM In Research Collaboration To Transform Parkinson's Disease Care (RTTNews)
07.04.16	Shire Says Proposed Merger With Baxalta On Track To Close In Mid-2016 (RTTNews)
07.04.16	BIND In A Fix, APRI To File NDA In Q3, TSRO Abuzz (RTTNews)
06.04.16	Pfizer Terminates $160 Bln Merger Deal With Allergan (RTTNews)
06.04.16	Pfizer, Allergan Terminate Merger (RTTNews)
06.04.16	The U.S. Gets 2nd Biosimilar, ORMP Awaits Data This Qtr, PFE Hits Mark In OPAL (RTTNews)
06.04.16	Pfizer Reportedly Decides To Terminate Merger With Allergan (RTTNews)
05.04.16	Merck, Pfizer Begins Phase III Combination Trial For Advanced Renal Cell Cancer (RTTNews)
05.04.16	Merck KGaA, Pfizer: First Patient Treated In Phase III Study Of Avelumab, Inlyta (RTTNews)
05.04.16	Merck KGaA, Darmstadt, Germany, and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell Carcinoma (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

26.11.24		Dow Jones aktuell: Dow Jones zum Handelsende in Grün
26.11.24		Börse New York: Dow Jones wenig verändert
26.11.24		Verluste in New York: Dow Jones legt den Rückwärtsgang ein
26.11.24		FTSE 100 aktuell: FTSE 100 fällt zum Handelsende
26.11.24		Schwache Performance in Europa: Euro STOXX 50 schlussendlich leichter
26.11.24		Gewinne in Frankfurt: TecDAX zum Handelsende im Aufwind
26.11.24		Schwacher Handel: SPI sackt schlussendlich ab

26.11.24

Dow Jones aktuell: Dow Jones zum Handelsende in Grün

26.11.24

Börse New York: Dow Jones wenig verändert

26.11.24

Verluste in New York: Dow Jones legt den Rückwärtsgang ein

26.11.24

FTSE 100 aktuell: FTSE 100 fällt zum Handelsende

26.11.24

Schwache Performance in Europa: Euro STOXX 50 schlussendlich leichter

26.11.24

Gewinne in Frankfurt: TecDAX zum Handelsende im Aufwind